• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
[Expert recommendations on homogenization management of the diagnosis and treatment of rare diseases in children].[儿童罕见病诊疗同质化管理专家建议]
Zhongguo Dang Dai Er Ke Za Zhi. 2023 Jul 15;25(7):663-671. doi: 10.7499/j.issn.1008-8830.2304036.
2
[Clinical diagnostic techniques for rare genetic diseases in children: current status, advances, and thoughts].[儿童罕见遗传病的临床诊断技术:现状、进展与思考]
Zhongguo Dang Dai Er Ke Za Zhi. 2023 Mar 15;25(3):308-314. doi: 10.7499/j.issn.1008-8830.2211010.
3
development of a therapeutic approach to rare cancers in children: the Children's Oncology Group experience.儿童罕见癌症治疗方法的发展:儿童肿瘤学组的经验
J Pediatr Hematol Oncol. 2012 May;34 Suppl 2:S37-8. doi: 10.1097/MPH.0b013e31824e378e.
4
Management options for rare diseases in children and adolescents in Georgia (experience of the country with transitional economy).格鲁吉亚儿童和青少年罕见病的管理方案(转型经济国家的经验)
Georgian Med News. 2011 Apr(193):8-11.
5
Australian families living with rare disease: experiences of diagnosis, health services use and needs for psychosocial support.澳大利亚罕见病患者家庭:诊断经历、卫生服务利用情况以及对心理社会支持的需求。
Orphanet J Rare Dis. 2013 Feb 11;8:22. doi: 10.1186/1750-1172-8-22.
6
7
Interface management concepts in healthcare for rare diseases in Germany: a study protocol for a mixed-methods study to develop best practice recommendations.德国罕见病医疗保健中的界面管理概念:一项混合方法研究的研究方案,旨在制定最佳实践建议。
BMJ Open. 2020 Nov 30;10(11):e040470. doi: 10.1136/bmjopen-2020-040470.
8
[Interdisciplinary care path and potential IT support for people with rare diseases in Germany].[德国罕见病患者的跨学科护理路径及潜在的信息技术支持]
Z Evid Fortbild Qual Gesundhwes. 2021 Oct;165:68-76. doi: 10.1016/j.zefq.2021.06.004. Epub 2021 Sep 3.
9
[Healthcare for people with rare diseases: recommendations for successful intersectoral collaboration].[罕见病患者的医疗保健:成功开展跨部门合作的建议]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2023 Aug;66(8):940-948. doi: 10.1007/s00103-023-03719-y. Epub 2023 Jun 13.
10
Educational aspects of rare and orphan lung diseases.罕见和孤儿肺疾病的教育方面。
Respir Res. 2021 Mar 24;22(1):92. doi: 10.1186/s12931-021-01676-1.

本文引用的文献

1
[Clinical diagnostic techniques for rare genetic diseases in children: current status, advances, and thoughts].[儿童罕见遗传病的临床诊断技术:现状、进展与思考]
Zhongguo Dang Dai Er Ke Za Zhi. 2023 Mar 15;25(3):308-314. doi: 10.7499/j.issn.1008-8830.2211010.
2
[Early recognition, diagnosis and treatment of spinal muscular atrophy].
Zhonghua Er Ke Za Zhi. 2023 Mar 2;61(3):286-288. doi: 10.3760/cma.j.cn112140-20221116-00976.
3
[China guideline for pharmaceutical care on anti-tumor antibody-based drugs].《中国抗肿瘤抗体类药物药学服务指南》
Zhonghua Zhong Liu Za Zhi. 2022 Oct 23;44(10):1017-1046. doi: 10.3760/cma.j.cn112152-20220902-00593.
4
[Expert consensus on rehabilitation management of the spinal muscular atrophy].[脊髓性肌萎缩症康复管理专家共识]
Zhonghua Er Ke Za Zhi. 2022 Sep 2;60(9):883-887. doi: 10.3760/cma.j.cn112140-20220315-00201.
5
The Human Phenotype Ontology in 2021.2021 年人类表型本体论。
Nucleic Acids Res. 2021 Jan 8;49(D1):D1207-D1217. doi: 10.1093/nar/gkaa1043.
6
Why is misdiagnosis more likely among some people with rare diseases than others? Insights from a population-based cross-sectional study in China.为什么一些罕见病患者比其他人更容易误诊?基于中国人群的横断面研究的见解。
Orphanet J Rare Dis. 2020 Oct 28;15(1):307. doi: 10.1186/s13023-020-01587-2.
7
Orphan drug clinical development.孤儿药临床开发。
Therapie. 2020 Apr;75(2):141-147. doi: 10.1016/j.therap.2020.02.004. Epub 2020 Feb 13.
8
[A practice-based competencies training, certifying and evaluating system for genetic counseling in the United States].
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2019 Jan 10;36(1):37-43. doi: 10.3760/cma.j.issn.1003-9406.2019.01.007.
9
Whole-exome sequencing in the evaluation of fetal structural anomalies: a prospective cohort study.全外显子组测序在胎儿结构畸形评估中的应用:一项前瞻性队列研究。
Lancet. 2019 Feb 23;393(10173):758-767. doi: 10.1016/S0140-6736(18)32042-7. Epub 2019 Jan 31.
10
Integration of genomics and metabolomics for prioritization of rare disease variants: a 2018 literature review.基因组学和代谢组学整合用于优先考虑罕见疾病变异:2018 年文献回顾。
J Inherit Metab Dis. 2018 May;41(3):435-445. doi: 10.1007/s10545-018-0139-6. Epub 2018 May 2.

[儿童罕见病诊疗同质化管理专家建议]

[Expert recommendations on homogenization management of the diagnosis and treatment of rare diseases in children].

出版信息

Zhongguo Dang Dai Er Ke Za Zhi. 2023 Jul 15;25(7):663-671. doi: 10.7499/j.issn.1008-8830.2304036.

DOI:10.7499/j.issn.1008-8830.2304036
PMID:37529946
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10414169/
Abstract

Rare diseases in children are characterized by low prevalence, complex pathogenesis, variety, and difficulty in the diagnosis and treatment. With the development of medical services, progress has been made in the diagnosis and treatment of rare diseases. However, due to asymmetric allocation of medical resources at different levels, there are still many shortcomings in the establishment and promotion of the homogenized management system of rare disease diagnosis and treatment. In order to further standardize the homogenized management of rare diseases in children, achieve early and accurate diagnosis and treatment, and improve the quality of life of the children, the Rare Disease Diagnosis and Treatment Center of Tianjin Children's Hospital (Tianjin University Children's Hospital) invited relevant experts in the field to develop recommendations for the management model of homogenized diagnosis and treatment of rare diseases in children from the aspects of information construction, hierarchical diagnosis and treatment, personnel training, scientific popularization, and multi-participation. The recommendations provide reference for the regional homogenization of clinical diagnosis and treatment management system for children with rare diseases.

摘要

儿童罕见病具有患病率低、发病机制复杂、病种多样以及诊断和治疗困难等特点。随着医疗服务的发展,罕见病的诊断和治疗取得了进展。然而,由于不同层面医疗资源分配不均衡,在建立和推进罕见病诊疗同质化管理体系方面仍存在诸多不足。为进一步规范儿童罕见病的同质化管理,实现早期准确诊断和治疗,提高患儿生活质量,天津市儿童医院(天津大学儿童医院)罕见病诊疗中心邀请该领域相关专家,从信息建设、分级诊疗、人才培养、科普宣传及多方参与等方面,制定儿童罕见病同质化诊疗管理模式的建议。这些建议为儿童罕见病临床诊疗管理体系的区域同质化提供参考。